SUNPHARMA:NSE
Sun Pharmaceutical Industries Ltd
1.758,80 INR
arrow_downward
−0,29%(−5,20) 1D
16. lis, 15:30:00 GMT+5:30 · INR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za SUNPHARMA...
Otvori
1.762,20 INR
Najviša
1.764,90 INR
Najniža
1.743,50 INR
Trž. kap.
4,22 bil.
Prosj. kol.
1,45 mil.
Količina
1,52 mil.
Dividenda
0,91 %
Kvartalna dividenda
4,00 INR
Datum nakon isplate dividende
7. srp 2026.
P/E omjer
34,87
52-tjed. najviša
2.046,90 INR
52-tjed. najniža
1.583,70 INR
EPS
50,44 INR
Dionice u optjecaju
0,00
Broj djelatnika
47 tis.
Otvori
1.762,20 INR
Najviša
1.764,90 INR
Najniža
1.743,50 INR
Trž. kap.
4,22 bil.
Prosj. kol.
1,45 mil.
Količina
1,52 mil.
Dividenda
0,91 %
Kvartalna dividenda
4,00 INR
Datum nakon isplate dividende
7. srp 2026.
P/E omjer
34,87
52-tjed. najviša
2.046,90 INR
52-tjed. najniža
1.583,70 INR
EPS
50,44 INR
Dionice u optjecaju
0,00
Broj djelatnika
47 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
ad-hoc-news.de
·
prije 55 minuta
Crisil rates Sun Pharma debt AAA. Sun Pharma stock is valued at INR 4.2 trillion
ad-hoc-news.de
·
prije 20 sati
Analyst consensus puts Sun Pharma stock at INR 2,180.00
Moneycontrol.com
·
prije 2 dana
Sun Pharma: Tariff relief, innovation brighten growth outlook
ad-hoc-news.de
·
prije 2 dana
Geojit raises target for Sun Pharma stock to INR 2,070.00
Profil
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.
Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
Sun Pharmaceutical Industries Ltd – informacije
Glavni izvršni direktor-
Zaposlenici47 tis.
Osnovano1983
SjedišteGoregaon East, Mumbai, Indija
Sektor-
Web-lokacijasunpharma.com